Forian Inc. (NASDAQ:FORA - Get Free Report)'s share price traded down 1.5% during trading on Monday . The company traded as low as $2.01 and last traded at $2.02. 17,048 shares traded hands during mid-day trading, an increase of 3% from the average session volume of 16,557 shares. The stock had previously closed at $2.05.
Forian Price Performance
The firm has a market capitalization of $60.53 million, a P/E ratio of -21.56 and a beta of 1.00. The company has a fifty day moving average of $2.06 and a 200 day moving average of $2.12.
Forian (NASDAQ:FORA - Get Free Report) last issued its quarterly earnings results on Wednesday, May 14th. The company reported ($0.04) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.02 by ($0.06). The firm had revenue of $7.06 million for the quarter, compared to analysts' expectations of $5.37 million.
Institutional Inflows and Outflows
Hedge funds have recently made changes to their positions in the business. Renaissance Technologies LLC lifted its position in shares of Forian by 48.9% during the 4th quarter. Renaissance Technologies LLC now owns 35,301 shares of the company's stock valued at $73,000 after acquiring an additional 11,601 shares during the period. Virtu Financial LLC acquired a new position in shares of Forian during the fourth quarter valued at about $30,000. Finally, Oracle Investment Management Inc. raised its holdings in shares of Forian by 0.7% during the fourth quarter. Oracle Investment Management Inc. now owns 1,366,107 shares of the company's stock valued at $2,814,000 after purchasing an additional 10,000 shares during the period. 19.25% of the stock is owned by institutional investors.
About Forian
(
Get Free Report)
Forian Inc provides a suite of data management capabilities, and information and analytics solutions to optimize and measure operational, clinical, and financial performance for customers in the healthcare and related industries. It develops commercial, real world evidence (RWE), and market access solutions and proprietary data-driven insights, as well as offers data management solutions.
Further Reading
Before you consider Forian, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Forian wasn't on the list.
While Forian currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
